oral paclitaxel for patients with recurrent or metastatic breast cancer
Published 3 years ago • 56 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
8:05
oral paclitaxel yields better outcomes than iv paclitaxel in metastatic breast cancer
-
3:27
tesetaxel plus capecitabine for patients with metastatic breast cancer
-
1:57
dr. rugo on results of oral paclitaxel with encequidar in metastatic breast cancer
-
4:34
paclitaxel with pertuzumab plus trastuzumab in metastatic breast cancer
-
6:09
nab-paclitaxel in metastatic breast cancer
-
6:17
tesetaxel plus reduced-dose capecitabine among patients with hr /her2- metastatic breast cancer
-
8:25
study of nab-paclitaxel with pembrolizumab for patients with hr /her2- breast cancer
-
23:05
the first orally administered paclitaxel shown to be superior to iv paclitaxel
-
1:10
rebastinib and paclitaxel for advanced/metastatic ovarian cancer
-
1:06
meteora-ii: metronomic vex versus paclitaxel in er /her2- metastatic breast cancer
-
3:02
neoadjuvant alpelisib plus nab-paclitaxel for triple-negative breast cancer
-
1:33
dr. hope rugo on the first-line superiority of paclitaxel for advanced breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
0:53
treating metastatic breast cancer with metronomic vex in the meteora-ii trial
-
4:45
atezolizumab plus nab-paclitaxel for advanced triple negative breast cancer
-
9:03
taxol (paclitaxel) chemotherapy for breast cancer: side effects, benefits, and what to expect
-
7:11
chemotherapeutics in metastatic breast cancer
-
6:45
dr. shalini singh: diagnostic for metastatic breast cancer patients with low her2 expression
-
1:42
dr. rugo on chemotherapy for metastatic breast cancer